Relationship between glucose exposure via peritoneal dialysis solutions and coronary artery calcification in non-diabetic peritoneal dialysis patients

International Urology and Nephrology

Volumn 44, Issue 6, 2012, Pages 1847-1853

  Sevinc Ok, Ebru ^a   Asci, Gulay ^a   Kircelli, Fatih ^a   Duman, Soner ^a   Dheir, Hamad ^a   Sezis Demirci, Meltem ^a   Ozkahya, Mehmet ^a   Toz, Huseyin ^a   Ok, Ercan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Coronary artery calcification; Glucose exposure; Insulin resistance; Peritoneal dialysis

Indexed keywords

CALCIUM; GLUCOSE; PERITONEAL DIALYSIS FLUID; VITAMIN D;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DISEASE ASSOCIATION; DRUG USE; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN RESISTANCE; MALE; PATIENT ASSESSMENT; PERITONEAL DIALYSIS; PREDICTION; SEX RATIO; AGED; BLOOD VESSEL CALCIFICATION; CHEMICALLY INDUCED DISORDER; CORONARY ARTERY DISEASE; MIDDLE AGED;

ADULT; AGED; CORONARY ARTERY DISEASE; FEMALE; GLUCOSE; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; VASCULAR CALCIFICATION; YOUNG ADULT;

EID: 84877601784     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0138-8     Document Type: Article

References (43)

1. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938-942
2. Kondos GT, Hoff JA, Sevrukov A, Daviglus ML, Garside DB, Devries SS, Chomka EV, Liu K (2003) Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 107:2571-2576
3. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transpl 18:1731-1740
4. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483
5. Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K (2002) Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61:638-647
6. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39:695-701
7. Stompór T, Pasowicz M, Sulłowicz W, Dembińska- Kieć A, Janda K, Wójcik K, Tracz W, Zdzienicka A, Klimeczek P, Janusz-Grzybowska E (2003) An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 41:203-211
8. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC (1996) Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394-401
9. Tamashiro M, Iseki K, Sunagawa O, Inoue T, Higa S, Afuso H, Fukiyama K (2001) Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 38:64-69
10. McCullough PA, Sandberg KR, Dumler F, Yanez JE (2004) Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review. J Nephrol 17:205-215
11. Hujairi NM, Afzali B, Goldsmith DJ (2004) Cardiac calcification in renal patients: what we do and don't know. Am J Kidney Dis 43:234-243
12. Ammirati AL, Dalboni MA, Cendoroglo M, Draibe SA, Santos RD, Miname M, Canziani ME (2007) The progression and impact of vascular calcification in peritoneal dialysis patients. Perit Dial Int 27:340-346
13. Chen NX, Duan D, O'Neill KD, Moe SM (2006) High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transpl 21:3435-3442
14. Wang CC, Sorribas V, Sharma G, Levi M, Draznin B (2007) Insulin attenuates vascular smooth muscle calcification but increases vascular smooth muscle cell phosphate transport. Atherosclerosis 195:e65-e75
15. Fadini GP, Pauletto P, Avogaro A, Rattazzi M (2007) The good and the bad in the link between insulin resistance and vascular calcification. Atherosclerosis 193:241-244
16. Ahmadi N, Tirunagaram S, Hajsadeghi F, Flores F, Saeed A, Hecht H, Naghavi M, Budoff M (2010) Concomitant insulin resistance and impaired vascular function is associated with increased coronary artery calcification. Int J Cardiol 144:163-165
17. Reilly MP, Wolfe ML, Rhodes T, Girman C, Mehta N, Rader DJ (2004) Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation 110:803-809
18. Fortes PC, de Moraes TP, Mendes JG, Stinghen AE, Ribeiro SC, Pecoits-Filho R (2009) Insulin resistance and glucose homeostasis in peritoneal dialysis. Perit Dial Int 29(Suppl 2):S145-S148
19. Park JT, Chang TI, Kim DK, Lee JE, Choi HY, Kim HW, Chang JH, Park SY, Kim E, Yoo TH, Han DS, Kang SW (2010) Metabolic syndrome predicts mortality in non-diabetic patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transpl 25:599-604
20. Tatar E, Demirci MS, Kircelli F, Gungor O, Turan MN, Sevinc Ok E, Asci G, Ozkahya M, Ok E (2011) Association of insulin resistance with arterial stiffness in nondiabetic peritoneal dialysis patients. Int Urol Nephrol. 2011 Jun 4 [Epub ahead of print]
21. Holmes CJ (2009) Reducing cardiometabolic risk in peritoneal dialysis patients: role of the dialysis solution. J Diabetes Sci Technol 3:1472-1480
22. Davies SJ, Phillips L, Naish PF, Russell GI (2001) Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12:1046-1051
23. Twardowski ZJ (1989) Clinical value of standardized equilibration tests in CAPD patients. Blood Purif 7:95-108
24. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R (1990) Quantification of coronary artery calcification using ultrafast computed tomography. J Am Coll Cardiol 15:827-832
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
26. Taniwaki H, Ishimura E, Tabata T, Tsujimoto Y, Shioi A, Shoji T, Inaba M, Inoue T, Nishizawa Y (2005) Aortic calcification in haemodialysis patients with diabetes mellitus. Nephrol Dial Transplant 20:2472-2478
27. Jean G, Bresson E, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C (2009) Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transpl 24:948-955
28. Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, He J (2003) Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14:469-477
29. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y (2002) Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13:1894-1900
30. Kobayashi S, Oka M, Maesato K, Ikee R, Mano T, Hidekazu M, Ohtake T (2008) Coronary artery calcification, ADMA, and insulin resistance in CKD patients. Clin J Am Soc Nephrol 3:1289-1295
31. Jiang N, Qian J, Lin A, Lindholm B, Axelsson J, Yao Q (2008) Initiation of glucose-based peritoneal dialysis is associated with increased prevalence of metabolic syndrome in non-diabetic patients with end-stage renal disease. Blood Purif 26:423-428
32. Szeto CC, Chow KM, Kwan BC, et al. (2007) New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis. Am J Kidney Dis 49:524-532
33. de Moraes TP, Pecoits-Filho R (2009) Metabolic impact of peritoneal dialysis. Contrib Nephrol 163:117-123
34. Ammirati AL, Dalboni MA, Cendoroglo M, Draibe SA, Fernandes Canziani ME (2006) Coronary artery calcification, systemic inflammation markers and mineral metabolism in a peritoneal dialysis population. Nephron Clin Pract 104:c33-c40
35. Stompór TP, Pasowicz M, Sułowicz W, Dembińska- Kieć A, Janda K, Wójcik K, Tracz W, Zdzienicka A, Konieczyńska M, Klimeczek P, Janusz-Grzybowska E (2004) Trends and dynamics of changes in calcification score over the 1-year observation period in patients on peritoneal dialysis. Am J Kidney Dis 44:517-528
36. Chertow GM, Burke SK (2002) Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245-252
37. Yamada K, Fujimoto S, Nishiura R, Komatsu H, Tatsumoto M, Sato Y, Hara S, Hisanaga S, Ochiai H, Nakao H, Eto T (2007) Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis. Nephrol Dial Transpl 22:2032-2037
38. Ok E, Asci G, Duman S, Ozkahya M, Ceylan M, Toz H, Faugere MC, Malluche HH (2008) Reduction of calcium exposure slows down progression of vascular calcification and improves adynamic bone disease. Clin J Am Soc Nephrol 3:RB01-RB04: LB005
39. Bhaskaran S, Schaubel DE, Jassal SV, Thodis E, Singhal MK, Bargman JM, Vas SI, Oreopoulos DG (2000) The effect of small solute clearances on survival of anuric peritoneal dialysis patients. Perit Dial Int 20:181-187
40. Szeto CC, Wong TY, Chow KM, Leung CB, Law MC, Wang AY, Lui SF, Li PK (2001) Impact of dialysis adequacy on the mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 12:355-360
41. Tintut Y, Patel J, Parhami F, Demer LL (2000) Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102:2636-2642
42. Shioi A, Katagi M, Okuno Y, Mori K, Jono S, Koyama H, Nishizawa Y (2002) Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res 91:9-16
43. Schlieper G, Brandenburg V, Djuric Z, Damjanovic T, Markovic N, Schurgers L, Kruger T, Westenfeld R, Ackermann D, Haselhuhn A, Dimkovic S, Ketteler M, Floege J, Dimkovic N (2009) Risk factors for cardiovascular calcifications in non-diabetic Caucasian haemodialysis patients. Kidney Blood Press Res 32:161-168